Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2

Targeted drug conjugates based on Affibody molecules fused to an albumin-binding domain (ABD) for half-life extension have demonstrated potent anti-tumor activity in preclinical therapeutic studies. Furthermore, optimization of their molecular design might increase the cytotoxic effect on tumors and...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Tianqi Xu, Jie Zhang, Maryam Oroujeni, Maria S. Tretyakova, Vitalina Bodenko, Mikhail V. Belousov, Anna Orlova, Vladimir Tolmachev, Anzhelika Vorobyeva, Torbjörn Gräslund
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2022-02-01
Schriftenreihe:	Pharmaceutics
Schlagworte:	affibody molecule human epidermal growth factor receptor 2 HER2 SKOV3 emtansine DM1
Online-Zugang:	https://www.mdpi.com/1999-4923/14/3/522
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!